Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Abroad (travel likely)RecruitingPHASE3

Conditions

Polyarticular Course Juvenile Idiopathic Arthritis (JIA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of California San Francisco Pediatric Rheumatology, San Francisco, California, United States

    Study coordinator · zilan.zheng@ucsf.edu · 415-353-1301
    Contact: Principal Investigator (Susan Kim)
  • University of Florida, Gainesville, Florida, United States

    Contact: Principal Investigator (Melissa Elder)
  • Hackensack Meridian Health - Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, United States

    Contact: Study coordinator (Clinical Research Coordinator) · kate.sidwell@hmhn.org · 551-996-3345
    Contact: Principal Investigator (Ginger Janow)
  • Nationwide Children's Hospital, Columbus, Ohio, United States

    Contact: Principal Investigator (Alysha Taxter)
  • Asklepios Children's Hospital, Sankt Augustin, North Rhine-Westphalia, Germany

    Contact: Study coordinator (Jana Kipp) · j.kipp@asklepios.com · +49 (2241) 249-201
    Contact: Study coordinator (Verena Lutz-Wiegers) · v.lutz@asklepios.com
    Contact: Principal Investigator (Gerd Horneff, Prof. Dr.)
  • IRCCS Giannina Gaslini Institute, Genoa, Liguria, Italy

    Contact: Study coordinator (Research Assistant) · elisapatrone@gaslini.org · +39 010 56361
    Contact: Principal Investigator (Alessandro Consolaro)